Status:

ENROLLING_BY_INVITATION

Effects of Social Determinants of Health on IV Iron Treatments

Lead Sponsor:

BayCare Health System

Collaborating Sponsors:

University of South Florida

Conditions:

Social Determinants of Health (SDOH)

Eligibility:

All Genders

18+ years

Brief Summary

This study investigates how social determinants of health (SDOH) like income, employment, transportation, food, and housing affect patients' ability to receive IV iron treatments. It aims to understan...

Eligibility Criteria

Inclusion

  • Patients receiving one of the following IV iron products: Ferric Carboxymaltose, Ferric Derisomaltose, Ferumoxytol, Iron Sucrose, or Iron Dextran
  • Patients 18 years of age or older
  • Patients who speak English or Spanish

Exclusion

  • Patients receiving an alternative IV iron product: Sodium ferric gluconate
  • Patients under 18 years of age
  • Patients who do not speak English or Spanish

Key Trial Info

Start Date :

November 5 2024

Trial Type :

OBSERVATIONAL

Allocation :

ESTIMATED

End Date :

January 1 2026

Estimated Enrollment :

130 Patients enrolled

Trial Details

Trial ID

NCT06591182

Start Date

November 5 2024

End Date

January 1 2026

Last Update

November 7 2024

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

St. Josephs Hospital Adult Infusion Center

Tampa, Florida, United States, 33607